JNJ COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge 5 years ago Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one… Johnson & Johnson (JNJ) Q3 2020 Earnings Call Transcript 5 years ago Johnson & Johnson (NYSE: JNJ) Q3 2020 earnings call dated Oct. 13, 2020 Corporate Participants: Christopher DelOrefice — Vice President of Investor… Johnson & Johnson (JNJ) Q3 earnings: Infographic 5 years ago Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported… Johnson & Johnson (JNJ) Q2 2020 Earnings Call Transcript 6 years ago Johnson & Johnson (NYSE: JNJ) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Chris DelOrefice — Vice President, Investor Relations… Johnson & Johnson (JNJ): Postponement of procedures hits medical devices unit hard in Q2 6 years ago Johnson & Johnson (NYSE: JNJ) saw revenue and earnings decline for the second quarter of 2020 but both the top… Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement 6 years ago Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today. Reported sales decreased 10.8% to $18.3 billion. GAAP… Johnson & Johnson (NYSE: JNJ) Q1 2020 Earnings Call Transcript 6 years ago Johnson & Johnson (JNJ) Q1 2020 earnings call dated Apr. 14, 2020. Corporate Participants: Chris DelOrefice — Vice President, Investor Relations Alex… A visual representation of Johnson & Johnson (JNJ) Q1 2020 earnings results 6 years ago Johnson & Johnson (NYSE: JNJ) reported that its first-quarter 2020 earnings and revenue came in above the analysts’ expectations citing… Johnson & Johnson (NYSE: JNJ) Q4 2019 Earnings Conference Call Transcript 6 years ago Johnson & Johnson (NYSE: JNJ) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations… Johnson & Johnson (JNJ) beats Q4 earnings estimates, misses on revenue 6 years ago Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations.… Next» « Previous